Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Oncogene|April 6, 2004
Suppression of glioblastoma tumorigenicity by the Kruppel-like transcription factor KLF6Alec C Kimmelman, Rui F Qiao, Goutham Narla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2006
Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal disseminationAnalisa DiFeo, Goutham Narla, Jennifer Hirshfeld, et al.
American Journal of Clinical Oncology|March 14, 1998
Daily low-dose subcutaneous recombinant interleukin-2 by alternate weekly administration: antitumor activity and immunomodulatory effectsP Tagliaferri, C Barile, M Caraglia, et al.
International Journal of Cancer|July 11, 2007
KLF6 allelic loss is associated with tumor recurrence and markedly decreased survival in head and neck squamous cell carcinomaMiriam S Teixeira, Olga Camacho-Vanegas, Yolanda Fernandez, et al.
Cold Spring Harbor Molecular Case Studies|October 11, 2018
Detection of endometrial precancer by a targeted gynecologic cancer liquid biopsyJohn A Martignetti, Deep Pandya, Nimesh Nagarsheth, et al.
European Journal of Cancer (Oxford, England : 1990)|December 23, 2008
Functional role of the KLF6 tumour suppressor gene in gastric cancerJaya Sangodkar, Jiayan Shi, Analisa DiFeo, et al.
The Journal of Clinical Investigation|July 4, 2008
KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasisGoutham Narla, Analisa DiFeo, Yolanda Fernandez, et al.
Gastroenterology|April 2, 2004
Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancerHelen L Reeves, Goutham Narla, Olagunju Ogunbiyi, et al.
Gastroenterology|May 13, 2008
Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinomaSteven Yea, Goutham Narla, Xiao Zhao, et al.
Neoplasia (New York, N.Y.)|February 25, 2014
Personalized ovarian cancer disease surveillance and detection of candidate therapeutic drug target in circulating tumor DNAJohn A Martignetti, Olga Camacho-Vanegas, Nolan Priedigkeit, et al.
Pageof 12